Theravance Biopharma, Inc. (16) | Uncategorized (6)
- Offer Letter with Richard Graham August 12, 2015 (Filed With SEC on November 9, 2020)
- Brett K. Haumann Transfer to Theravance Biopharma UK Ltd. Memo (Filed With SEC on May 8, 2020)
- Brett K. Haumann Theravance Biopharma UK Ltd. Contract of Employment (Filed With SEC on May 8, 2020)
- First Amendment of Registration Rights Agreement with Glaxo Group Limited (Filed With SEC on May 8, 2020)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2020)
- Offer Letter with Andrew Hindman dated May 30, 2019 (Filed With SEC on August 5, 2019)
